Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    HIV [CONDITION] AND (pregnancy OR perinatal) [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
1 Unknown  Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
Condition: HIV Infections
2 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy
3 Recruiting Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
Conditions: HIV Infections;   Hepatitis B
4 Recruiting Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Condition: HIV Infections
Interventions: Drug: atazanavir/cobicistat;   Drug: darunavir/ritonavir;   Drug: darunavir/cobicistat;   Drug: etravirine;   Drug: elvitegravir/cobicistat;   Drug: dolutegravir;   Drug: tenofovir alafenamide fumarate (TAF);   Drug: TAF/cobicistat;   Drug: TAF/ritonavir;   Drug: efavirenz;   Drug: lopinavir/ritonavir;   Drug: nevirapine;   Drug: rifampicin;   Drug: ethambutol;   Drug: isoniazid;   Drug: pyrazinamide;   Drug: kanamycin;   Drug: amikacin;   Drug: capreomycin;   Drug: moxifloxacin;   Drug: levofloxacin;   Drug: ofloxacin;   Drug: ethionamide/prothionamide;   Drug: terizidone/cycloserine;   Drug: para-aminosalicylic acid (PAS);   Drug: high dose isoniazid (INH);   Drug: bedaquiline;   Drug: clofazamine;   Drug: delamanid;   Drug: linezolid;   Drug: pretomanid;   Drug: atazanavir/ritonavir/tenofovir;   Drug: ethinyl estradiol oral contraceptive;   Drug: etonogestrel implant
5 Recruiting Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
Conditions: HIV;   Pregnancy
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
6 Recruiting Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Efavirenz;   Drug: Raltegravir
7 Recruiting The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy
Conditions: HIV;   Contraception
Interventions: Other: HEC Placebo Gel;   Other: Placebo Vaginal Insert;   Other: Placebo Vaginal Film;   Other: Placebo Intravaginal ring (IVR)
8 Recruiting Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Condition: HIV Infections
9 Recruiting Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART
Conditions: HIV;   Infant Exposure to Efavirenz
10 Recruiting Evaluation of an Integrated Economic Strengthening and HIV Prevention Program for Vulnerable Youth in South Africa
Conditions: HIV;   HIV Infections
Interventions: Behavioral: Economic Strengthening (Impumelelo);   Behavioral: HIV Prevention Education (Vhutshilo 2.2)
11 Recruiting Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria
Conditions: HIV;   HIV Infections;   Pregnancy;   Infant, Newborn, Diseases
Intervention: Behavioral: Conditional Cash Transfers
12 Unknown  Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV
Conditions: HIV;   Hepatitis B
Interventions: Drug: Tenofovir/lamivudine/lopinavir-ritonavir;   Drug: Zidovudine/lamivudine/lopinavir-ritonavir
13 Recruiting SSAT063- Pharmacokinetics of Efavirenz 400 mg Once Daily During Pregnancy in HIV-1 Infected Women
Condition: HIV
Interventions: Drug: Efavirenz;   Drug: tenofovir /emtricitabine;   Drug: tenofovir/lamivudine;   Drug: lamivudine/zidovudine
14 Recruiting Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women
Conditions: PNC Vaccine;   HIV-infected Pregnant Women
Interventions: Biological: PPV-23;   Biological: PCV-10;   Other: NaCl
15 Unknown  Preventing Health Damaging Behaviors in Male and Female Army Recruits
Conditions: Sexually Transmitted Infection (STI) Prevention;   Unintended Pregnancy Prevention;   Sexual Risk Reduction;   Alcohol and Other Substance Use Prevention;   Intimate Partner Violence Prevention
Intervention: Behavioral: Staying Safe & In Control: Increasing Knowledge and Building Skills to Prevent STIs and Unintended Pregnancy
16 Recruiting A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women
Conditions: HIV;   HIV Infections;   Pregnancy
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: Etravirine;   Drug: Rilpivirine;   Drug: Darunavir/Cobicistat (FDC)
17 Unknown  Study of Cell Phone SMS Messages for Prevention of Maternal to Child Transmission of HIV
Condition: HIV Infections
Intervention: Behavioral: cell phone sms text messaging
18 Recruiting EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
Condition: Pregnancy Related
19 Recruiting Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors
Condition: Maternal-fetal Infection Transmission
Intervention: Drug: darunavir monotherapy
20 Not yet recruiting Promoting CSD500 Use Among Women in Established Relationships
Conditions: PSA;   Unprotected Sex
Interventions: Device: CSD500 Condom;   Device: Standard Condom;   Behavioral: Condom Counseling

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Indicates status has not been verified in more than two years